| Clonal Hematopoiesis Diversity in Aplastic Anemia - When Does It Matter Clinically? |
|
The New England Journal of Medicine |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Real-World Effectiveness and Safety of Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria: Evidence From the International PNH Registry |
|
American Journal of Hematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Donor age and type in allogeneic haematopoietic stem cell transplantation: Strong effect in MDS, limited in AML |
|
British Journal of Haematology |
Myelodysplastic Syndromes (MDS) |
| Clonal Dynamics of Hematopoiesis in Aplastic Anemia after Immunosuppression and Eltrombopag |
|
NEJM Evid |
Aplastic Anemia |
| Clonal Selection and Evolution after Treatment of Severe Aplastic Anemia |
|
NEJM Evid |
Aplastic Anemia |
| Real-World Effectiveness and Safety of Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria: Evidence From the International PNH Registry |
|
American Journal of Hematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| An Immune Dysfunction Signature Score Predicts Survival in MDS Patients: Insights From a Longitudinal, Multicenter Study |
|
Cancer Sci |
Myelodysplastic Syndromes (MDS) |
| Baseline IPSS-M vs pretransplant risk downstaging as prognostic determinants in MDS undergoing allogeneic transplantation |
|
Blood Advances |
Myelodysplastic Syndromes (MDS) |
| A novel approach to defining progression in MDS and precursor myeloid conditions in the MDS Natural History Study |
|
Blood Advances |
Myelodysplastic Syndromes (MDS) |
| Development and validation of the predictive aplastic score system (PASS): a simplified tool to diagnose acquired aplastic anemia in adults |
|
Leukemia |
Aplastic Anemia |
